Animations for the COVID-19 RECOVERY Trial being run by The University of Oxford
The RECOVERY Trial is a very large clinical trial aiming to identify possible treatments for Covid-19. It has very quickly recruited thousands of patients in NHS hospitals across the country.
We were initially approached to make one animation to explain how to carry out the trial for the medical teams in UK hospitals. The trial was designed to be as simple as possible for NHS staff to avoid any extra drain on their resources. So our animation explained the process in a simple direct style. We produced the animation in around a week and a half which is a record.
“This is by far the largest trial in the world”, Professor Peter Horby, University of Oxford.
We quickly moved onto a second Patient Information animation. This is very much our bread and butter and involves turning the Patient or Participant Information Sheet into an overview animation. The thinking is that it will cover all of the key information but is supported by the Patient Information Sheet. We needed to be flexible to change both animations at the very last minute as the trial itself changed to include children.
RECOVERY trial patient information animation
The animations that Morph provided for the RECOVERY trial were really well-received by participants and study staff alike. They have really helped explain the trial to patients at a stressful time in their care and we were delighted with the thought and care that Morph put into helping us develop them.
Professor Richard Haynes, University of Oxford
RECOVERY trial project images
Digitrial by Morph
Digitrial Digital Patient Information by Morph Animation and Web Studio
Digitrial by Morph
Digital Patient Information
Interested in working with us to deliver Digital Patient Information for your clinical trial?
Our creative web solutions use animation and video to explain clinical research and drive medical trial recruitment.
Developed with the University of York, funded by NIHR and approved by NHS Research Ethics Committees on multiple live trials.